ArticlePharmaceutics2022

Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis.

Maria Garcia-Cremades et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.